Steve Tutewohl - Mar 3, 2022 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Operating Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Mar 3, 2022
Transactions value $
-$52,361
Form type
4
Date filed
3/7/2022, 04:09 PM
Previous filing
Mar 4, 2022
Next filing
Jul 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Sale -$52.4K -1.92K -1.74% $27.30 108K Mar 3, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.78, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.